World Courier Integrates SAVSU Technologies’ Next Generation of Dry Shippers with its Global Cell and Gene Therapy Logistics Platform

January 23, 2018

Wider choice of cryogenic shipping options available to customers for critical biologic shipments


London, UK and Albuquerque, NM (January 22, 2018) - World Courier, the global leader in specialty logistics and a part of AmerisourceBergen, today announced the availability of SAVSU Technologies’ smart precision shipping containers throughout its network. SAVSU designs and manufactures innovative high-performance cloud-connected passive storage and transport containers optimized for the cell and gene therapy supply chain.

The combination of World Courier’s global logistics network and SAVSU’s patent pending, enhanced temperature-controlled evo DV4 & DV10 liquid nitrogen (LN2)  shippers will enable cell and gene therapy developers to more efficiently and effectively move critical biologic shipments at cryogenic temperatures worldwide, with enhanced visibility and shipment monitoring capabilities.

The addition of these shippers to World Courier’s packaging fleet connects therapy developers to the latest cold chain technologies, and offers a greater choice of options for cryogenic shipping. This extends World Courier’s track record of developing and verifying the latest technology through its Climate Optimisation Research and Engineering (CORE) Labs, to provide its customers with access to a wide range of market-leading packaging solutions.

The combination of World Courier and evo LN2 dry vapor shippers offer significant value to cell and gene therapy developers by providing:

  • Short lead times, enabled by SAVSU’s rapid charging and availability throughout World Courier’s 140+ owned office global network
  • High quality and extended temperature performance, underpinned by the transformative design of evo smart shippers and world-class specialty logistics capabilities of World Courier
  • Low cost profile as a result of reduced shipper weight and dimensions
  • Real time data visibility and traceability through the evo.is SaaS dashboard, amplified into actionable information by the global reach of World Courier to intervene and remediate if required
  • Seamless integration of shipping container supply and logistics, coupled with full vein-to-vein traceability for customers through integration with cell orchestration platforms

Sam Herbert, World Courier President, commented, “This collaboration enables our customers to benefit from innovative technology at both clinical and commercial scales and ensures that World Courier remains the leading partner for cell and gene therapy developers .”

Bruce McCormick, President and CTO of SAVSU, commented that “by partnering with World Courier, we are now able to provide customers with a new level of service and peace of mind for their personalized medicine and other biologic shipments, on a global scale.”

World Courier is working to realize the full potential of cell and gene therapies for both patients and manufacturers.  At the same time, the company aims to improve supply chain performance for the global healthcare market by providing more reliable and cost-effective clinical trial and commercial product transport.

About World Courier

World Courier is a global specialty logistics company that designs world-class supply chain programs in complete alignment with customers’ business goals. The company delivers ultimate peace of mind for the transport and storage of time- and temperature-sensitive products. For more than 45 years, only World Courier has delivered the unsurpassed knowledge, global reach and flawless supply chain execution needed to become the most trusted specialty logistics company in the world. For more information, visit worldcourier.com.

About SAVSU

SAVSU is the leading designer and manufacturer of innovative high-performance cloud-connected passive storage and transport containers for high-value, temperature-sensitive biologics and pharmaceuticals. Our mission is to improve global health by greatly reducing the waste and risks associated with the improper freezing and overheating of thermal-sensitive medicines and biologics. SAVSU has developed proprietary state-of-the-art technology to ultimately lower costs and improve delivery of these most essential materials. For more information please visit www.savsu.com.

About AmerisourceBergen 

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work — and powered by our 20,000 associates — we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $150 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.